Przejdź do treści

Aptamer-driven medtech solutions to improve chronic kidney disease patients’ life​

about
us

Doto Medical LLC is a European medtech company aiming to improve the quality of life and survival rate of patients with chronic kidney disease. We engage the aptamer-driven therapeutic engine to bring hemodialysis to the next stage and develop it into a targeted therapy.

Within our portfolio, we are developing an aptamer-based medical device called ABD (for Adjunctive Blood Detoxification), designed to be an add-on to currently available kidney replacement machines, in order to safely and specifically remove toxins from CKD patients’ blood. We focus on achieving a therapeutic effect by restoring water homeostasis, reducing proinflammatory cytokines, and reducing negative cardiovascular effects of kidney failure in patients.

our
portfolio

media &
investors

Doto Medical LLC is a European medtech company aiming to improve the quality of life and survival rate of patients with chronic kidney disease. We engage the aptamer-driven therapeutic engine to bring hemodialysis to the next stage and develop it into a targeted therapy.